-+ 0.00%
-+ 0.00%
-+ 0.00%

ESTRELLA IMMUNOPHARMA INITIATES SECOND COHORT AND DOSES FIRST PATIENT IN STARLIGHT-1 TRIAL OF EB103 IN ADVANCED B-CELL NON-HODGKIN’S LYMPHOMAS

Reuters·05/29/2025 12:01:00

Please log in to view news